Australia's largest stock trading and investment forum Australia's #1 stock forum

MAY

5.26%

3.6¢ melbana energy limited

Ann: Block 9, Alameda-3 Appraisal Update, page-461

First 461 Last

Share
Profile

Follow
Kit67

7,897 Posts.

1031

19/06/24

14:43

Post #: 74391926
Share

Originally posted by afawcett: ↑

cosmo,

An exact answer may be difficult to determine but I think that a side-track isn't required at this point. They will likely do an acid washout and see if that works, from my understanding they were getting influx so it's unlikely they were overbalanced unless the pressure regime is very complex with all the fractures etc.

We will see. Hopefully the remedy works and we can get flows.

Anyway the alameda flow tests should be commencing shortly and that will be exciting stuff. The other option is to drill the Marti section old school and see what flows can be achieved up to safety limits.

best of luck holders

Expand

Silly question from me: Can they extract the slotted liners? (is that a pain in the A to do?)

MAY Price at posting: 4.6¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BUX

Buxton projects new graphite province discovery at WA Narryer play

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

There are more pages in this discussion • 296 more messages in this thread...

First 461 Last

Add MAY (ASX) to my watchlist

(20min delay)
Last 3.6¢		Change -0.002(5.26%)		Mkt cap ! $121.3M

Open	High	Low	Value	Volume
3.6¢	3.7¢	3.5¢	$40.16K	1.116M

Buyers (Bids)

No.	Vol.	Price($)
6	670068	3.5¢

Sellers (Offers)

Price($)	Vol.	No.
3.6¢	13422	1

View Market Depth

No.	Vol.	Price($)
6	670068	0.035
9	654962	0.034
6	1767551	0.033
2	362500	0.032
7	799801	0.031

Price($)	Vol.	No.
0.036	13422	1
0.038	802430	5
0.039	698060	5
0.040	904244	5
0.041	465955	4

Last trade - 16.10pm 04/10/2024 (20 minute delay)

MAY (ASX) Chart

Ann: Block 9, Alameda-3 Appraisal Update, page-461

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Block 9, Alameda-3 Appraisal Update, page-461

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Buxton projects new graphite province discovery at WA Narryer play

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News